Coxarthrosis; Primary Clinical Trial
Official title:
The Efficacy of Pulse Radiofrequency Treatment to Articular Branches of Femoral and Obturator Nerves in Patients With Coxarthrosis
Verified date | February 2024 |
Source | Ankara City Hospital Bilkent |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Our aim in this interventional study is to investigate the effectiveness of pulsed radiofrequency (PRF) treatment applied to the articular branches of the femoral and obturator nerves on pain, functional level, functional capacity and quality of life in patients with coxarthrosis. We will compare the effects of PRF treatment added to nerve block compared to nerve block alone.
Status | Completed |
Enrollment | 28 |
Est. completion date | November 25, 2023 |
Est. primary completion date | November 25, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years to 85 Years |
Eligibility | Inclusion Criteria: - Patients with unilateral and/or bilateral hip pain for more than 6 months who meet the diagnosis of coxarthrosis according to the American College of Rheumatology(ACR) criteria - Pain intensity greater than 3 according to the visual analog pain scale - Stage =2 hip osteoarthritis according to the Kellgren-Lawrence classification - Ambulation with or without support - Having the mental competence to express pain scores - Signing an informed consent form stating consent to participate in the study Exclusion Criteria: - Other non-degenerative causes of hip pain (Avascular necrosis, femoraacetebular impingement syndrome, thoracenteric bursitis) - Concomitant central nervous system and/or peripheral nervous system disease - History of lower extremity fracture/surgery in the last 6 months - Local infection on the hip or presence of systemic infection - Conditions where fluoroscopy-guided injection is contraindicated like pregnancy, contrast material allergy, local anesthetic allergy, coagulopathy - Presence of unstable systemic diseases |
Country | Name | City | State |
---|---|---|---|
Turkey | Ankara Bilkent City Hospital | Ankara |
Lead Sponsor | Collaborator |
---|---|
Ankara City Hospital Bilkent |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Visual Analogue Scale (VAS) | Visual Analogue Scale (VAS) is one of the pain rating scales. The amount of pain that a patient feels ranges across a continuum from none to an extreme amount of pain. The VAS consists of a 10 cm line, with two end points representing 0 (no pain) and 10 (extreme pain). At rest, with movement, nighttime VAS scores and averages of them will be recorded. | baseline, week 2, week 4 and week 12 | |
Secondary | Active Range of Motion | Active ROM is a joint movement that can be achieved by active muscle contraction without the aid of external forces. It will be measured with a goniometer by physician. | baseline, week 2, week 4 and week 12 | |
Secondary | Passive Range of Motion | Passive ROM is joint motion that can be achieved with the help of external forces. It will be measured with a goniometer by physician. | baseline, week 2, week 4 and week 12 | |
Secondary | Harris Hip Score (HHS) | HHS is a measure of dysfunction for the hip joint. It consists of 4 parts including pain, function, absence of deformity and range of motion. Scores range from 0 to 100. Higher scores mean less dysfunction. | baseline, week 2, week 4 and week 12 | |
Secondary | Six Minute Walk Test | 6-minute walk test is used to measure the functional capacity of the person. A 30-meter-long, flat and hard-floored walking path is used. The start and end points are marked with cones. The distance that walked over 6 minutes will be recorded. Higher distance indicates better functional capacity. | baseline, week 2, week 4 and week 12 | |
Secondary | Short From-36 (SF-36) | Sf-36 is a questionare that measure health related quality of life. It includes 36 questions and assesses 8 health domains: physical functionality, role limitations due to physical health, role limitations due to emotional problems, energy/fatigue, emotional well-being, social functioning, pain and general health perceptions. Scores for each domain range from 0 to 100. A higher score identifies a better state of health. | baseline, week 2, week 4 and week 12 | |
Secondary | Number of analgesics | The number of analgesic drugs used daily by the patient is recorded. | baseline, week 2, week 4 and week 12 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05547984 -
Ceramic Modular Dual Mobility in Primary Total Hip Arthroplasty (THA)
|
N/A | |
Active, not recruiting |
NCT04943328 -
Cemented TrendHip® - Multicenter PMCF Study on Total Indications
|
N/A | |
Recruiting |
NCT04587440 -
Is the Dynamic of the Pelvic Bone Altered After a Total Hip Replacement ?
|
N/A | |
Withdrawn |
NCT05763368 -
Evaluation of Proprioception in Patients With Total Hip Replacement
|
N/A |